We provide you with 20 years of free, institutional-grade data for PEPG stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PEPG. Explore the full financial landscape of PEPG stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about PEPG stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
PepGen Inc.(NASDAQ:PEPG) 
PepGen Inc., a clinical-stage biotechnology company, is focused on the development of oligonucleotide therapeutics for use in the treatment of serious neurological and neuromuscular diseases. The company is headquartered in Cambridge, Massachusetts.
Website: https://pepgen.com/
Founded: 2018
IPO Price: $12 (May 06, 2022)
Sector: TECHNOLOGY
Industry: GENERAL
Share this website to your friends